An Evaluation of the FreeStyle Libre Flash Glucose Monitoring System

Sponsor
Jessa Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03071159
Collaborator
(none)
90
1
1
12
7.5

Study Details

Study Description

Brief Summary

Medium-term (6-12 months) evaluation of the use, the identified problems, the usability and the effect on the metabolic control of the FreeStyle Flash Libre glucose monitoring system in 90 children by questionnaires and routine measurement of HbA1c values.

Condition or Disease Intervention/Treatment Phase
  • Device: FreeStyle Flash Libre glucose monitoring system
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Medium-term Evaluation of the Use, the Identified Problems, the Usability and the Effect on the Metabolic Control of the FreeStyle Flash Libre Glucose Monitoring System
Actual Study Start Date :
Mar 10, 2017
Anticipated Primary Completion Date :
Mar 10, 2018
Anticipated Study Completion Date :
Mar 10, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: cases

children (4-18 years) with type 1 diabetes mellitis using the FreeStyle Flash Libre glucose monitoring system (standard care)

Device: FreeStyle Flash Libre glucose monitoring system
glucose monitoring system with sensors

Outcome Measures

Primary Outcome Measures

  1. Usability of the FreeStyle Flash Libre glucose monitoring system [6-12 months follow up]

    Usability of the FreeStyle Flash Libre glucose monitoring system by a questionnaire

Secondary Outcome Measures

  1. Problems associated with the FreeStyle Flash Libre glucose monitoring system [6-12 months follow up]

    Problems associated with the FreeStyle Flash Libre glucose monitoring system by a questionnaire

  2. The effect of the FreeStyle Flash Libre glucose monitoring system on the metabolic control in patients [6-12 months follow up]

    The effect of the FreeStyle Flash Libre glucose monitoring system on the metabolic control in patients by measurement of the HbA1c values

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Type 1 diabetes mellitis

  • Being followed in the Pediatric Diabetes Unit of the Jessa Hospital

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jessa Hospital Hasselt Belgium 3500

Sponsors and Collaborators

  • Jessa Hospital

Investigators

  • Study Director: Guy Massa, MD, PhD, Department of Pediatric Diabetology, Jessa Ziekenhuis, Stadsomvaart 11, B3500

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jessa Hospital
ClinicalTrials.gov Identifier:
NCT03071159
Other Study ID Numbers:
  • JessaH
First Posted:
Mar 6, 2017
Last Update Posted:
Jan 23, 2018
Last Verified:
Feb 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jessa Hospital

Study Results

No Results Posted as of Jan 23, 2018